TE
TELA.KL
—
Bursa Malaysia
Diversified Medical Equipment & Supplies
Teladan Group Bhd
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
1,27 %
Op margin
15,4 %
ROE
5,0 %
Net margin
9,2 %
Debt / equity
0,58
Beta
—
52w range
—
Volume
491
Day range
$0,89–$0,97
Prev close
$0,90
Open
$0,89
Next earnings
2026-10-28
Ex-dividend
—
TR 1Y
—
About
Teladan Group Bhd operates in the real estate rental, development, and operations sector, generating revenue primarily through property development and management.
Business. Teladan Group Bhd (TELA.KL) is a real estate company engaged in rental, development, and operations activities. The firm is headquartered in Malaysia and is primarily listed on the Bursa Malaysia stock exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Classification99 %
SectorHealth Care
Industry groupDiversified Medical Equipment & Supplies
Generated · model-assisted
Sell-side consensus
BUY5 analysts
4 buy1 hold0 sell
Avg 12m price target2,25
Analyst recommendations
5 analysts · consensus BuyBuy4
Hold1
Sell0
12-month price target
2,25
Consensus of sell-side coverage.
At a glance
Score
—
not yet scored
Valuation
—
valuation pending
Analysts→
Buy
5 analysts · indicative
Ownership→
UBS Financial Services, Inc.
largest disclosed fund holder
Profitability→
5,0 %
return on equity
Quality
—
not yet scored
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
— missing data
News & coverage
0Sector rotation
Sector1D1Mvs mkt
Materials+2,3 %+6,6 %+1,7 %
Communication Services+2,2 %−5,5 %+1,6 %
Energy+0,6 %+3,3 %+0,0 %
Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
Information Technology+0,6 %+6,7 %+0,0 %
Consumer Discretionary+0,4 %+7,6 %−0,2 %
Financials−0,3 %−2,8 %−0,9 %
Consumer Staples−0,4 %+2,5 %−1,0 %
Real Estate−0,7 %+10,9 %−1,3 %
Industrials−1,9 %−3,1 %−2,5 %
Utilities−1,9 %+28,2 %−2,5 %
Developing storylines
No tracked sagas currently linked to TELA.KL. Browse all sagas →
Analysis
AI analysis
Generated · analysis pipeline · tier hybrid · as of 2026-08-04
↑ At a glance
Opportunity
— missing data
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
— missing data
Signals & dispatch
peak dispatch · —
Composite-score breakdown
Synthesis
Business
Teladan Group Bhd (TELA.KL) is a real estate company engaged in rental, development, and operations activities. The firm is headquartered in Malaysia and is primarily listed on the Bursa Malaysia stock exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Classification99 %
SectorHealth Care
Industry groupDiversified Medical Equipment & Supplies
AI synthesis
GENERATEDTeladan Group Bhd maintains a debt-to-equity ratio of 0.58, indicating a relatively conservative capital structure. The company's liquidity position is assessed as medium, with a current ratio of 4.12, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints.
In terms of profitability, Teladan Group Bhd reports a return on equity (ROE) of 4.97% and a return on assets (ROA) of 2.75%. These figures are below the industry median for ROE and ROA in the real estate development and operations sector, indicating that the company is underperforming relative to its peers in terms of capital efficiency and asset utilization.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financial report. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes, which could impact future earnings.
Teladan Group Bhd's growth trajectory is modest, with no significant revenue growth reported in the latest period. The company's capital expenditure is minimal at -792,000 MYR, suggesting limited investment in new projects or infrastructure. This could indicate a focus on maintaining existing operations rather than pursuing aggressive expansion.
The company's risk profile is characterized by medium liquidity risk and low dilution potential. The negative net cash position after debt is a key flag, but the absence of recent dilutive events or share issuance plans suggests that equity dilution is not an immediate concern.
No recent events, such as filings or transcripts, have been disclosed in the latest financial data. This lack of recent activity may indicate a stable but uneventful operational environment, with no major strategic shifts or external pressures currently affecting the company.
Key takeaways
- Teladan Group Bhd has a conservative capital structure with a debt-to-equity ratio of 0.58.
- The company's ROE and ROA are below industry medians, indicating underperformance in capital efficiency and asset utilization.
- Revenue is concentrated in a single segment with no geographic diversification, increasing exposure to regional risks.
- Growth is limited, with minimal capital expenditure and no significant revenue growth in the latest period.
- Liquidity risk is medium, and dilution risk is low, with no recent dilutive events reported.
Bull / Bear case
Generated · model-assisted— missing data
In focus — financials by report
Valuation
Market price
$0,79
Market cap
—
Enterprise valueⓘ
—
P/Eⓘ
—
Non-GAAP P/Eⓘ
—
EV / Revenueⓘ
—
EV / Op incomeⓘ
—
EV / OCFⓘ
—
P / Bⓘ
—
P / Tangible bookⓘ
—
Tangible book
$566.0M
Net cashⓘ
-$262.0M
Current ratioⓘ
4.1
Debt / equityⓘ
0.6
ROAⓘ
2.8%
ROEⓘ
5.0%
Cash conversionⓘ
394.0%
CapEx / revenueⓘ
-0.3%
SBC / revenueⓘ
—
Dilution ratioⓘ
0.0%
Revenue by segment
Hernia Repair Devices—
low · business_description · 2026-07-03
Plastic & Reconstructive Surgery Devices—
low · business_description · 2026-07-03
Surgical Mesh & Fixation Devices—
low · business_description · 2026-07-03
Business relationships
Business relationships3 disclosed relationships · 1 type · extracted from filings & disclosures
Subsidiaries3
EX21:d30e4f264aceEX21:d30e4f264aceSubsidiarie97%
EX21:daa9777b5404EX21:daa9777b5404Subsidiarie97%
EX21:f95ee3e62a1eEX21:f95ee3e62a1eSubsidiarie97%
Supply chain
— missing data
Peer comparison
Peer comparison8 peers · vs TELA · multiples and returns
AB
ABT—
Abbott Laboratories
$107,13
187,2B USDP/E
26,3x
— vs self
Div yield
2,4 %
— vs self
ROE
12,5 %
+627,6 vs self
MD
MDT—
Medtronic PLC
$86,19
110,3B USDP/E
21,4x
— vs self
Div yield
3,4 %
— vs self
ROE
9,7 %
+624,8 vs self
MD
MDLN—
MEDLINE INC.
$40,47
53,2B USDP/E
202,6x
— vs self
Div yield
—
— vs self
ROE
—
— vs self
SY
SYK—
Stryker Corp
$341,20
131,8B USDP/E
38,0x
— vs self
Div yield
—
— vs self
ROE
13,5 %
+628,6 vs self
BD
BDX—
Becton Dickinson And Co
$170,21
48,4B USDP/E
25,6x
— vs self
Div yield
2,8 %
— vs self
ROE
7,0 %
+622,0 vs self
HS
HSIC—
Henry Schein Inc
$88,21
10,1B USDP/E
80,5x
— vs self
Div yield
—
— vs self
ROE
3,0 %
+618,1 vs self
BA
BAX—
Baxter International Inc
$28,10
14,5B USDP/E
—
— vs self
Div yield
2,3 %
— vs self
ROE
-15,4 %
+599,7 vs self
SO
SOLV—
SOLVENTUM CORPORATION
$76,83
13,3B USDP/E
8,6x
— vs self
Div yield
—
— vs self
ROE
30,8 %
+645,9 vs self
Market position
Stress test
— missing data
Predictor forecast
Next quarternear-term
Earnings · next quarterconf 45 %
EPS
Consensus EPS
-0,67
Predicted surprise
+0,00
Beat probability
45 %
Analysts
5
Other metrics
Revenue
—
no estimate
Segment revenue
—
no estimate
Margin
—
no estimate
Segment margin
—
no estimate
as of 2026-05-16 · Earnings Surprise V1
Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
Probabilistic model output — not investment advice. · generated 2026-08-04
Options
— missing data
Short squeeze
— missing data
Earnings-call key lines
— missing data
Estimate revisions
consensus EPS · 26-week trend— missing data
Sell-side observations
Low$1,00
Mean$2,25
Median$2,00
High$3,25
Spot$0,79
+184.8 %implied to mean12-month sell-side price targets · ▲ spot
Themes
— missing data
ESG
— missing data
Risk factors
Dilution riskLow
Liquidity riskMedium
Filing-based flags
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Op Margin15,4 %Above P75
Net Margin9,2 %Above median
ROE5,0 %Above median
Capex / Rev-0,3 %Above median
D/E0,58Below median
Cash Conv3,94Best in class
Corporate actions / M&A
— missing data
FX exposure
— missing data
Comparable transactions
— missing data
Derivatives & instruments
Derivative transactions
Net acquired 822 310 sh17 grants11 insiders
- Director · Stock Option (Right to Buy) → Common StockAcquired 17 335 @ $0,94grant · 2026-06-09
- Director · Stock Option (Right to Buy) → Common StockAcquired 17 550 @ $0,94grant · 2026-06-09
- Director · Stock Option (Right to Buy) → Common StockAcquired 17 335 @ $0,94grant · 2026-06-09
- Director · Stock Option (Right to Buy) → Common StockAcquired 17 335 @ $0,94grant · 2026-06-09
- Director · Stock Option (Right to Buy) → Common StockAcquired 17 550 @ $0,94grant · 2026-06-09
- Director · Stock Option (Right to Buy) → Common StockAcquired 17 335 @ $0,94grant · 2026-06-09
- Director · Stock Option (Right to Buy) → Common StockAcquired 17 335 @ $0,94grant · 2026-06-09
- Director · Stock Option (Right to Buy) → Common StockAcquired 17 550 @ $0,94grant · 2026-06-09
- Director · Stock Option (Right to Buy) → Common StockAcquired 17 335 @ $0,94grant · 2026-06-09
- Director · Stock Option (Right to Buy) → Common StockAcquired 17 550 @ $0,94grant · 2026-06-09
- President · Stock Option (Right to Buy) → Common StockAcquired 127 000 @ $0,72grant · 2026-02-20
- COO and CFO · Stock Option (Right to Buy) → Common StockAcquired 85 000 @ $0,72grant · 2026-02-20
- Chief Technology Officer · Stock Option (Right to Buy) → Common StockAcquired 85 000 @ $0,72grant · 2026-02-20
- Chief Business Officer · Stock Option (Right to Buy) → Common StockAcquired 55 000 @ $0,72grant · 2026-02-20
- Director, Chief Executive Officer · Stock Option (Right to Buy) → Common StockAcquired 261 000 @ $0,72grant · 2026-02-20
- Director · Stock Option (Right to Buy) → Common StockAcquired 17 550 @ $1,23grant · 2025-10-31
- Director · Stock Option (Right to Buy) → Common StockAcquired 17 550 @ $1,48grant · 2025-10-09
Actions
Ask Handelsavisen
— missing data
Data sources
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
How metrics are computed
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
Source documents
- Teladan Group Bhd Market data — financials · 2026-05-29
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2024-06-300,00 %$3M
- Investment Managers · as of 2025-12-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
Insider activity
Net buying1 buys · 0 sellsnet $4,0M13 insiders · last 365d
- Director · Common StockOther 11 675 · 2026-06-09
- Director · Common StockOther 11 925 · 2026-06-09
- Director · Common StockOther 11 675 · 2026-06-09
- Director · Common StockOther 11 675 · 2026-06-09
- Director · Common StockOther 11 925 · 2026-06-09
- Director · Common StockOther 11 675 · 2026-06-09
- Director · Common StockOther 11 925 · 2026-06-09
- Director · Common StockOther 11 675 · 2026-06-09
- Director · Common StockOther 11 925 · 2026-06-09
- Director · Common StockOther 11 675 · 2026-06-09
- Director, Chief Executive Officer · Common StockOther 3 900 @ $0,79$3K · 2026-02-24
- Chief Business Officer · Common StockOther 1 352 @ $0,77$1K · 2026-02-23
- Chief Technology Officer · Common StockOther 4 061 @ $0,77$3K · 2026-02-23
- Chief Accounting Officer · Common StockOther 423 @ $0,77$324 · 2026-02-23
- COO and CFO · Common StockOther 5 234 @ $0,77$4K · 2026-02-23
- Director, Chief Executive Officer · Common StockOther 11 631 @ $0,77$9K · 2026-02-23
- Director, Chief Executive Officer · Common StockOther 12 494 @ $0,72$9K · 2026-02-21
- Chief Business Officer · Common StockOther 4 189 @ $0,72$3K · 2026-02-21
- Chief Technology Officer · Common StockOther 3 385 @ $0,72$2K · 2026-02-21
- COO and CFO · Common StockOther 4 780 @ $0,72$3K · 2026-02-21
- Chief Accounting Officer · Common StockOther 1 590 @ $0,72$1K · 2026-02-21
- COO and CFO · Common StockOther 57 000 · 2026-02-20
- Chief Business Officer · Common StockOther 37 000 · 2026-02-20
- President · Common StockOther 86 000 · 2026-02-20
- Director, Chief Executive Officer · Common StockOther 176 000 · 2026-02-20
Short positioning
361.8Kshares short-22.4% vs prior
4.96days to cover
48.2%short of daily vol
4.0Kfails-to-deliver
as of 2026-07-15 · short-interest report (free)
Geographic breakdown
— missing data
Listings · one canonical issuer
all listings resolve to the canonical
TELA.KLCanonical
Bursa Malaysia · USD
Intel & risk
peak dispatch · —
OSINT findings
Dilution riskLow
Liquidity riskMedium
Net cash is negative after subtracting total debt.
Relationship graph
This companySectorSubsidiaries
Evidence & claims
From filings & derived data- Gross margin (FY 2025-12-31): 67.7%Derived (calculated)
- Net margin (FY 2025-12-31): -48.3%Derived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 35.3%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): 16.9%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 37.6%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 37.6%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): -3.5%Derived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): -54.7%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): 11.90xDerived (calculated)
- Current ratio (FY 2025-12-31): 4.20xDerived (calculated)
- Return on assets (FY 2025-12-31): -47.7%Derived (calculated)
- Return on equity (FY 2025-12-31): -614.6%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -2.6%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 32.2%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 1.1%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 4.6%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 15.8%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -77.8%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): -6.0%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 29.2%Derived (calculated)
- Long-term debt (annual): USD 55.65MSEC XBRL filing
- Operating income (annual): USD -33.76MSEC XBRL filing
- Current assets (annual): USD 75.58MSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES -1SEC XBRL filing
Showing 24 of 60 surfaced claims.
Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.
The Thread
Everything we know, in order2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
2026-06-09 00:00 UTCINSIDER20 insider transactions — 2026-06 10 derivative
2026-06-09INSIDERRocchio Betty Jo transacted 11.7k sh — Director
2026-06-09INSIDERCapper Joseph H transacted 11.9k sh — Director
2026-06-09INSIDERCapper Joseph H transacted 11.7k sh — Director
2026-06-09INSIDERPlovanic William J. transacted 11.7k sh — Director
2026-06-09INSIDERNEELS GUIDO J transacted 11.9k sh — Director
2026-06-09INSIDERNEELS GUIDO J transacted 11.7k sh — Director
2026-06-09INSIDERTHOMAS PAUL transacted 11.9k sh — Director
2026-06-09INSIDERTHOMAS PAUL transacted 11.7k sh — Director
2026-06-09INSIDERNOHRA GUY P transacted 11.9k sh — Director
2026-06-09INSIDERNOHRA GUY P transacted 11.7k sh — Director
2026-06-09INSIDERCapper Joseph H acquired 17.6k sh Stock Option (Right to Buy) — Director
2026-06-09INSIDERNOHRA GUY P acquired 17.3k sh Stock Option (Right to Buy) — Director
2026-06-09INSIDERNOHRA GUY P acquired 17.6k sh Stock Option (Right to Buy) — Director
2026-06-09INSIDERTHOMAS PAUL acquired 17.3k sh Stock Option (Right to Buy) — Director
2026-06-09INSIDERTHOMAS PAUL acquired 17.6k sh Stock Option (Right to Buy) — Director
2026-06-09INSIDERNEELS GUIDO J acquired 17.3k sh Stock Option (Right to Buy) — Director
2026-06-09INSIDERNEELS GUIDO J acquired 17.6k sh Stock Option (Right to Buy) — Director
2026-06-09INSIDERPlovanic William J. acquired 17.3k sh Stock Option (Right to Buy) — Director
2026-06-09INSIDERRocchio Betty Jo acquired 17.3k sh Stock Option (Right to Buy) — Director
2026-06-09INSIDERCapper Joseph H acquired 17.3k sh Stock Option (Right to Buy) — Director
2026-02-24 00:00 UTCINSIDER23 insider transactions — 2026-02 5 derivative
2026-02-24INSIDERKOBLISH ANTONY transacted 3.9k sh — Director, Chief Executive Officer ~$3k
2026-02-23INSIDERFirestone Gregory A. transacted 1.4k sh — Chief Business Officer ~$1k
2026-02-23INSIDERTalmo Paul transacted 4.1k sh — Chief Technology Officer ~$3k
2026-02-23INSIDERSmeykal Megan transacted 423 sh — Chief Accounting Officer ~$0k
2026-02-23INSIDERCuca Roberto transacted 5.2k sh — COO and CFO ~$4k
2026-02-23INSIDERKOBLISH ANTONY transacted 11.6k sh — Director, Chief Executive Officer ~$9k
2026-02-21INSIDERKOBLISH ANTONY transacted 12.5k sh — Director, Chief Executive Officer ~$9k
2026-02-21INSIDERFirestone Gregory A. transacted 4.2k sh — Chief Business Officer ~$3k
Showing the 40 most recent of 61 entries.
The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04
Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data
Premium coverage